The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes

Accounts of Chemical Research

Volumn 39, Issue 5, 2006, Pages 354-361

  Goldring, William P D ^a,b   Pattenden, Gerald ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRIDGED COMPOUND; EPOXIDE; FUSED HETEROCYCLIC RINGS; PHOMACTIN A; TAXANE; TAXOID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; ISOLATION AND PURIFICATION; SYNTHESIS;

ANIMALS; BRIDGED COMPOUNDS; EPOXY COMPOUNDS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MOLECULAR STRUCTURE; PLATELET ACTIVATING FACTOR; TAXOIDS;

EID: 33745683595     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar050186c     Document Type: Article

References (55)

1. Sugano, M.; Sato, A.; Iijima, Y.; Oshima, T.; Furuya, K.; Kuwano, H.; Hata, T.; Hanzaw, H. Phomactin A: A Novel PAF Antagonist from a Marine Fungus Phoma sp. J. Am. Chem. Soc. 1991, 113, 5463-5464.
2. (a) Chu, M.; Patel, M. G.; Gullo, V. P.; Truumees, I.; Puar, M. S.; McPhail, A. T. Sch 47918: A Novel PAF Antagonist from the Fungus Phoma sp. J. Org. Chem. 1992, 57, 5817-5818.
3. (b) Chu, M.; Truumees, I.; Gunnarsson, I.; Bishop, W. R.; Kreutner, W.; Horan, A. C.; Patel, M. G.; Gullo, V. P.; Puar, M. S. A Novel Class of Platelet Activating Factor Antagonists from Phoma sp. J. Antibiot. 1993, 46, 554-563.
4. (c) Sugano, M.; Sato, A.; Iijima, Y.; Furuya, K.; Haruyama, H.; Yoda, K.; Hata, T. Phomactins, Novel PAF Antagonists from Marine Fungus Phoma sp. J. Org. Chem. 1994, 59, 564-569.
5. (d) Sugano, M.; Sato, A.; Iijima, Y.; Furuya, K.; Kuwano, H.; Hata, T. Phomactin E, F, and G: New Phomactin-group PAF Antagonists from a Marine Fungus Phoma sp. J. Antibiot. 1995, 48, 1188-1190.
6. Koyama, K.; Ishino, M.; Takatori, K.; Sugita, T.; Kinoshita, K.; Takahashi, K. Phomactin H, a Novel Diterpene from an Unidentified Marine-Derived Fungus. Tetrahedron Lett. 2004, 45, 6947-6948.
7. (a) Lin, X.; Hezari, M.; Koepp, A. E.; Floss, H. G.; Croteau, R. Mechanism of Taxadiene Synthase, a Diterpene Cyclase that Catalyzes the First Step of Taxol Biosynthesis in Pacific Yew. Biochemistry 1996, 35, 2968-2977.
8. (b) Williams, D. C.; Carroll, B. J.; Jin, Q.; Rithner, C. D.; Lenger, S. R.; Floss, H. G.; Coates, R. M.; Williams, R. M.; Croteau, R. Intramolecular Proton Transfer in the Cyclization of Geranylgeranyl Diphosphate to the Taxadiene Precursor of Taxol Catalyzed by Recombinant Taxadiene Synthase. Chem. Biol. 2000, 7, 969-977.
9. (c) Chow, S. Y.; Williams, H. J.; Huang, Q.; Nanda, S.; Scott, A. I. Studies on Taxadiene Synthase: Interception of the Cyclisation Cascade at the Isocembrene Stage with GGPP Analogues. J. Org. Chem. 2005, 70, 9997-10003.
10. Mahato, S. B.; Pal, B. C.; Kawasaki, T.; Miyahara, K.; Tanaka, O.; Yamasaki, K. Structure of Cleomeolide, a Novel Diterpene Lactone from Cleome icosandra Linn. J. Am. Chem. Soc. 1979, 101, 4720-4723.
11. (a) Goldring, W. P. D.; Pattenden, G. A Total Synthesis of Phomactin A. Chem. Commun. 2002, 1736-1737.
12. (b) Cheing, J. W. C.; Goldring, W. P. D.; Pattenden, G. Synthetic Studies Towards Congeners of Phomactin A. Reexamination of the Structure of Sch 49028. Chem. Commun. 2003, 2788-2789.
13. (c) Diaper, C. M.; Goldring, W. P. D.; Pattenden, G. A Total Synthesis of (±)-Phomactin A. Org. Biomol. Chem. 2003, 1, 3949-3956.
14. (d) Goldring, W. P. D.; Pattenden, G. Total Synthesis of (±)-Phomactin G, a Platelet Activating Factor Antagonist from the Marine Fungus Phoma sp. Org. Biomol. Chem. 2004, 2, 466-473.
15. Braquet, P.; Touqui, L.; Shen, T. Y.; Vargaftig, B. B. Perspectives in Platelet-Activating Factor Research. Pharm. Rev. 1987, 39, 97-145.
16. (a) Cooper, K.; Parry, M. J. PAF Antagonists. Annu. Rep. Med. Chem. 1989, 24, 81-90.
17. (b) Nogrady, T. Medicinal Chemistry - A Biochemical Approach; Oxford University Press: Oxford, U.K., 1988; p 330.
18. (a) Nakanishi, K. The Ginkgolides. Pure Appl. Chem. 1967, 14, 89-113.
19. (b) Maruyama, M.; Terahara, A.; Itagaki, Y.; Nakanishi, K. The Ginkgolides, I. Isolation and Characterization of the Various Groups. Tetrahedron Lett. 1967, 8, 299-302.
20. (c) Maruyama, M.; Terahara, A.; Itagaki, Y.; Nakanishi, K. The Ginkgolides. II. Derivation of Partial Structures. Tetrahedron Lett. 1967, 8, 303-308.
21. (d) Maruyama, M.; Terahara, A.; Nakadaira, Y.; Woods, M. C.; Nakanishi, K. The Ginkgolides. III. The Structure of the Ginkgolides. Tetrahedron Lett. 1967, 8, 309-313.
22. (e) Maruyama, M.; Terahara, A.; Nakadaira, Y.; Woods, M. C.; Takagi, Y.; Nakanishi, K. The Ginkgolides. IV. Stereochemistry of the Ginkgolides. Tetrahedron Lett. 1967, 8, 315-319.
23. (f) Woods, M. C.; Miura, I.; Nakadaira, Y.; Terahara, A.; Maruyama, M.; Nakanishi, K. The Ginkgolides. V. Some Aspects of Their NMR Spectra. Tetrahedron Lett. 1967, 8, 321-326.
24. (g) Braquet, P. The Ginkgolides: Potent Platelet-Activating Factor Antagonists Isolated from Ginkgo biloba L.: Chemistry, Pharmacology and Clinical Applications. Drugs Future 1987, 12, 643-699.
25. (h) Braquet, P.; Godfroid, J. J. PAF-Acether Specific Binding Sites: 2. Design of Specific Antagonists. Trends Pharmacol. Sci. 1986, 7, 397-403.
26. (i) Barnes, P. J.; Chung, K. F. PAF Closely Mimics Pathology of Asthma. Trends Pharmacol. Sci. 1987, 8, 285-287.
27. (a) Bhat, S. V.; Bajwa, B. S.; Dornauer, H.; de Souza, N. J.; Fehlhaber, H.-W. Structures and Stereochemistry of New Labdane Diterpenoids from Coleus forskohlii briq. Tetrahedron Lett. 1977, 18, 1669-1672.
28. (b) Seamon, K. B. Forskolin and Adenylate Cyclase: New Opportunities in Drug Design. Annu. Rep. Med. Chem. 1984, 19, 293-302.
29. (a) Chang, M. N.; Han, G.-Q.; Arison, B. H.; Springer, J. P.; Hwang, S.-B.; Shen, T. Y. Neolignans from Piper futokadsura. Phytochemistry 1985, 24, 2079-2082.
30. (b) Shen, T. Y.; Hwang, S.-B.; Chang, M. N.; Doebber, T. W.; Lam, M. T.; Wu, M. S.; Wang, X.; Han, G. Q.; Li, R. Z. Characterization of a Platelet-Activating Factor Receptor Antagonist Isolated from Haifenteng (Piper futokadsura): Specific Inhibition of in Vitro and in Vivo Platelet-Activating Factor-Induced Effects. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 672-676.
31. Tokiwano, T.; Fukushi, E.; Endo T.; Oikawa, H. Biosynthesis of Phomactins: Common Intermediate Phomactatriene and Taxadiene. Chem. Commun. 2004, 1324-1325.
32. Groves, J. T.; Han, Y.-Z. Cytochrome P-450: Structure, Mechanism and Biochemistry, 2nd ed.; Ortiz de Montellano, P. R., Ed.; Plenum Press: New York, 1995; pp 8-14.
33. Giembycz, M. A.; Lindsay, M. A. Pharmacology of the Eosinophil. Pharm. Rev. 1999, 51, 213-339 and references therein.
34. Schiff, P. B.; Fant, J.; Horwitz, S. B. Promotion of Microtubule Assembly in vitro by taxol. Nature 1979, 277, 665-666.
35. For a synthesis of phomactin D, see: Miyaoka, H.; Saka, Y.; Miura, S.; Yamada, Y. Total Synthesis of Phomactin D. Tetrahedron Lett. 1996, 37, 7107-7110.
36. Mohr, P. J.; Halcomb, R. L. Total Synthesis of (+)-Phomactin A Using a B-Alkyl Suzuki Macrocyclization. J. Am. Chem. Soc. 2003, 125, 1712-1713.
37. Foote, K. M.; Hayes, C. J.; Pattenden, G. Synthetic Studies Towards Phomactin A. Concise Synthesis of the Novel Tricyclic Furanochroman System. Tetrahedron Lett. 1996, 37, 275-278.
38. Mohr, P. J.; Halcomb, R. L. Convergent Enantioselective Synthesis of the Tricyclic Core of Phomactin A. Org. Lett. 2002, 4, 2413-2416.
39. For another approach to the furanochroman core 31, see: (a) Chen, D.; Wang, J.; Totah, N. I. Dihydropyrones as Dienophiles in the Diels-Alder Reaction: Application to the Synthesis of 1-Oxadecalones. J. Org. Chem. 1999, 64, 1776-1777.
40. (b) Seth, P. P.; Totah, N. I. Synthesis of 1-Oxadecalones via the Lewis Acid-Catalyzed Dihydropyrone Diels-Alder Reaction. J. Org. Chem. 1999, 64, 8750-8753.
41. (c) Seth, P. P.; Chen, D.; Wang, J.; Gao, X.; Totah, N. I. The Dihydropyrone Diels-Alder Reaction: Development and Application to the Synthesis of Highly Functionalized 1-Oxa-4-decalones. Tetrahedron 2000, 56, 10185-10195.
42. (d) Seth, P. P.; Totah, N. I. Studies toward the Tricyclic Core of Phomactin A. Synthesis of the Reduced Furanochroman Subunit. Org. Lett. 2000, 2, 2507-2509.
43. (a) Marsden, A.; Thomas, E. J. An Approach to the Synthesis of Phomactins Using a Wittig Rearrangement. Arkivoc 2002, Part ix, 78-92.
44. (b) Balnaves, A. S.; McGowan, G.; Shapland, P. D. P.; Thomas, E. J. Approaches to the Total Synthesis of Phomactins. Tetrahedron Lett. 2003, 44, 2713-2716.
45. For a review that includes the scope for this coupling reaction in synthesis, see: Chemler, S. R.; Trauner, D.; Danishefsky, S. J. The B-Alkyl Suzuki-Miyaura Cross-Coupling Reaction: Development, Mechanistic Study, and Applications in Natural Product Synthesis. Angew. Chem., Int. Ed. 2001, 40, 4544-4568.
46. For a review that includes the scope for this coupling reaction in synthesis, see: Fürstner, A. Carbon-Carbon Bond Formations Involving Organochromium(III) Reagents. Chem. Rev. 1999, 99, 991-1045.
47. Kallan, N. C.; Halcomb, R. L. Synthesis of the Ring System of Phomactin D Using a Suzuki Macrocyclization. Org. Lett. 2000, 2, 2687-2690.
48. Chemler, S. R.; Danishefsky, S. J. Transannular Macrocyclization via Intramolecular B-Alkyl Suzuki Reaction. Org. Lett. 2000, 2, 2695-2698.
49. Foote, K. M.; John, M.; Pattenden, G. Synthesis of the Oxygenated Bicyclo[9.3.1]pentadecane Ring System of Phomactin A Using Chromium (II)-Mediated Macrocyclisation and Ring Closure Metathesis. Synlett 2001, 365-368.
50. Mi, B.; Maleczka, R. E. A Nozaki-Hiyama-Kishi Ni(II)/Cr(II) Coupling Approach to the Phomactins. Org. Lett. 2001, 3, 1491-1494.
51. Houghton, T. J.; Choi, S.; Rawal, V. H. Efficient Assembly of the Phomactin Core via Two Different Macrocyclization Protocols. Org. Lett. 2001, 3, 3615-3617.
52. Cole, K. P.; Hsung, R. P. Intramolecular Formal oxa-[3 + 3] Cycloaddition Approach to the ABD System of Phomactin A. Org. Lett. 2003, 5, 4843-4846.
53. Sugano, M.; Sato, A.; Saito, K.; Takaishi, S.; Matsushita, Y.; Iijima, Y. Structure-Activity Relationships of Phomactin Derivatives as Platelet Activating Factor Antagonists. J. Med. Chem. 1996, 39, 5281-5284.
54. Zhu, X.; Lambertino, A. T.; Houghton, T. J.; McGilvra, J. D.; Xu, C.; Rawal, V. H.; Leff, A. R. Structural Determinants of Blockade of Eosinophil Activation, Adhesion and Secretion by Synthetic Analogues of Phomactin. Life Sci. 2003, 73, 3005-3016.
55. Goldring, W. P. D.; Alexander, S. P. H.; Kendall, D. A.; Pattenden, G. Novel Phomactin Analogues as PAF Receptor Ligands. Bioorg. Med. Chem. Lett. 2005, 15, 3263-3266.